Evolent Health, Inc (EVH) insider trading
Every open-market stock purchase and sale by Evolent Health, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Daniel Joseph McCarthy (President) sold $329K in the last 90 days.
- Last insider buy: Brendan B Springstubb (Director), $38.2K, 10 months ago.
Last 12 months: insiders bought $38.2K (1 buy) and sold $329K (1 sale). Last close $4.59 on Aug 27, 2026.
Recent EVH insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 26, 2026 | Daniel Joseph McCarthy (President) | Sold | $329K |
| Jul 1, 2026 | Seth Blackley (CEO) | Sold (not open market) | $59.1K |
| Jul 1, 2026 | Daniel Joseph McCarthy (President) | Sold (not open market) | $26.3K |
| Jul 1, 2026 | Jonathan Weinberg (General Counsel) | Sold (not open market) | $15.2K |
| Jul 1, 2026 | Daniel Joseph McCarthy (President) | Bought (not open market) | — |
| Jul 1, 2026 | Aammaad Shams (C-suite exec) | Bought (not open market) | — |
| Jul 1, 2026 | Jonathan Weinberg (General Counsel) | Bought (not open market) | — |
| Jul 1, 2026 | Seth Blackley (CEO) | Bought (not open market) | — |
| Jun 4, 2026 | Craig A. Barbarosh (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Brendan B Springstubb (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Jill D. Smith (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Kim Keck (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Shawn M Guertin (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Peter J Grua (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Russell Monroe Glass (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Toyin Ajayi (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Richard M Jelinek (Director) | Bought (not open market) | — |
| Mar 3, 2026 | Seth Blackley (CEO) | Sold (not open market) | $84.4K |
| Mar 3, 2026 | Daniel Joseph McCarthy (President) | Sold (not open market) | $84.3K |
| Mar 3, 2026 | Jonathan Weinberg (General Counsel) | Sold (not open market) | $29K |
| Mar 3, 2026 | Aammaad Shams (C-suite exec) | Sold (not open market) | $15.1K |
| Mar 2, 2026 | Daniel Joseph McCarthy (President) | Sold (not open market) | $65.1K |
| Mar 2, 2026 | Seth Blackley (CEO) | Sold (not open market) | $63.5K |
| Mar 2, 2026 | Jonathan Weinberg (General Counsel) | Sold (not open market) | $6.8K |
| Mar 2, 2026 | Aammaad Shams (C-suite exec) | Sold (not open market) | $3K |
Who's trading EVH
- Daniel Joseph McCarthy, President: sold $329K (1 sale), last Aug 26, 2026
- Aammaad Shams, C-suite exec: other filings, last Jul 1, 2026
- Jonathan Weinberg, General Counsel: other filings, last Jul 1, 2026
- Seth Blackley, CEO: other filings, last Jul 1, 2026
- Russell Monroe Glass, Director: other filings, last Jun 4, 2026
- Richard M Jelinek, Director: other filings, last Jun 4, 2026
- Kim Keck, Director: other filings, last Jun 4, 2026
- Toyin Ajayi, Director: other filings, last Jun 4, 2026
- Craig A. Barbarosh, Director: other filings, last Jun 4, 2026
- Peter J Grua, Director: other filings, last Jun 4, 2026
- Shawn M Guertin, Director: other filings, last Jun 4, 2026
- Jill D. Smith, Director: other filings, last Jun 4, 2026
- Brendan B Springstubb, Director: bought $38.2K (1 buy), last Jun 4, 2026
- Mario Ramos, CFO: other filings, last Mar 2, 2026
Get free alerts when an insider at Evolent Health, Inc files a new trade →